Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2020 No.07

Total 21 articles

Revefenacin: a novel long-acting muscarinic antagonistWANG Yi-hua, LUO Ying, LIU Xiang-kui

721-725

Pharmacology and clinical evaluation of sphingosine-1-phosphate receptor modulator siponimodYANG Yan-yan, YU Li-ting, SHI Ai-xin

726-730

Crystal patent avoidance strategy for the development of generic drugXUE Ya-ping, WANG Dong-e, LIN Tao-xi

731-737

Development of new preparation technology of orally disintegrating tabletsZHANG Jun-jie, WANG Wei, LI Chen, ZHOU Si-yuan, ZHANG Bang-le

738-743

Progress in the prevention and treatment of thromboembolic diseases by rivaroxabanZHANG Xue-qin, YIN Xing-shuo, WANG Hao-yu, WANG Shu-mei

744-748

Risk management of phase Ⅰ clinical trials of anticancer drugsZHAO Shu-hua, LIU Xiao-hong, JIANG Min

749-752

Summary on the potential therapeutics against severe acute respiratory syndrome coronavirus 2JIA Yu-ting, CAI Yun, WANG Rui, WANG Jin

753-758

Key points of CRC management in hospital by drug clinical trial institutions under the first level response to major public health emergenciesDONG Yao, CAI Yun, LIANG Bei-bei, WANG Jin

759-761

Guidance for central pharmacy management of clinical drug research institutions based on grade Ⅰ response to major public health emergenciesJIA Yu-ting, CAI Yun, LIANG Bei-bei, WANG Jin

762-765

Investigation and analysis of the impact of severe acute respiratory syndrome coronavirus 2 outbreak on the development of GCPJIA Yu-ting, CAI Yun, LIANG Bei-bei, WANG Jin

766-772